There is currently no direct evidence linking Elmiron to eye damage. However, some experts believe that the drug could be a factor in causing or exacerbating certain eye conditions.
Elmiron is a medication used to treat interstitial cystitis (IC), a chronic inflammation of the bladder. The drug works by reducing the amount of urinaryfrequency and urgency, which are common symptoms of IC.
Elmiron is the only FDA-approved medication for IC, and it has been on the market since 1996. Since then, there have been reports of patients developing vision problems after taking Elmiron.
In 2006, the FDA issued a warning that Elmiron may be associated with an increased risk of developing macular degeneration, a condition that can lead to blindness. The FDA recommended that patients taking Elmiron be monitored for vision problems and report any changes to their doctor.
In 2018, the American Academy of Ophthalmology (AAO) issued a warning that Elmiron may be associated with a rare but serious eye condition called pigmentary maculopathy. The AAO recommended that patients taking Elmiron have their eyes examined regularly by an ophthalmologist.
If you have taken Elmiron and you are experiencing vision problems, it is important to see an eye doctor as soon as possible. Tim Miles Law Office is currently investigating potential lawsuits on behalf of patients who have suffered vision problems after taking Elmiron. If you or a loved one has been impacted by this, please contact us today for a free consultation.
